CapForce, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. The company is headquartered in Clarksburg, Maryland and currently employs 1 full-time employees. The company went IPO on 2015-05-05. The firm focuses on small-cap and mid-cap listing stocks underserved by bulge bracket investment banks. The company focuses on fintech-enabled and artificial intelligence (AI)-powered asset and wealth management services for its core investment banking clients across the world with the development of a digital investment banking platform designed to facilitate cross-border securities activities, AI-powered robo-advisory services, and technology-driven capitalization table management solutions. Its services include Niche Community-Focused Cross Border Stock Trading Platform, Big Data & AI-Powered Capital Market Services and Digitalized Wealth Management. Its Big Data & AI-Powered Capital Market Services areautomated cross-border public listing capital market sponsorship services for mid-sized growth-oriented companies.

Industry: Services-Medical Laboratories Peers: Rein Therapeutics Inc APPLIED GENETIC TECHNOLOGIES CORP Inhibitor Therapeutics Inc Viskase Holdings Inc Indaptus Therapeutics Inc Metacrine, Inc. Monopar Therapeutics Inc ONCOSEC MEDICAL Inc